We've found
6,735
archived clinical trials in
Psoriasis
We've found
6,735
archived clinical trials in
Psoriasis
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials